Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 70/100

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on ...

Wednesday, November 20, 2024 2 min read
Key Takeaway: Penumbra, Inc. has announced that its management team will present at the Piper Sandler 36th Annual Healthcare Conference scheduled for December 4, 2024. The presentation will be accessible via webcast, emphasizing the company's commitment to transparency and investor relations. Penumbra is recognized as a leader in thrombectomy technology, aiming to improve outcomes in various medical conditions. More information about the event and the company's innovations can be found on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra Inc. is showcasing its leadership and innovations in thrombectomy.
  • The company participates in significant industry events to highlight advancements.
  • Access to the webcast allows for widespread investor engagement.

Full Press Release Details

ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Piper Sandler 36 th Annual Healthcare Conference on Wednesday, December 4, 2024 .
Event: Piper Sandler 36 th Annual Healthcare Conference Date: Wednesday, December 4, 2024 Time: 8:00am ET / 5:00am PT
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations Penumbra, Inc. [email protected]
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

When is Penumbra's presentation at the healthcare conference?

Penumbra's presentation is on December 4, 2024, at 8:00am ET.

Where can I watch the Penumbra conference presentation?

The presentation can be accessed in the 'Events and Presentations' section on Penumbra's website.

How long will the webcast of the presentation be available?

The webcast will be available for at least two weeks after the event.

What is Penumbra's focus in medical technology?

Penumbra focuses on innovative thrombectomy technologies for conditions like strokes.

In how many countries does Penumbra operate?

Penumbra supports healthcare providers in over 100 countries worldwide.

Tags: PEN Viatris Investor Conferences Healthcare Penumbra thrombectomy healthcare conference investor relations Piper Sandler
Last updated: Nov 20, 2024